Activation of innate immune response pathways in MLL1-ELL-AML bone marrow progenitors could be due to mutations that constitutively activate inflammatory pathways or those that impair inactivation of a physiologic immune response. This evidence concerns the gene KMT2A and acute myeloid leukemia.